Design of PD-L1 inhibitors for lung cancer

The progression of lung cancer is associated with inactivation of programmed cell death protein 1, abbreviated as PD- 1 which regulates the suppression of the body's immune system by suppressing T- cell inflammatory activity and is responsible for preventing cancer cell growth. It is of interes...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Bioinformation
Main Authors: Udhwani, Trishang, Mukherjee, Sourav, Sharma, Khushboo, Sweta, Jajoriya, Khandekar, Natasha, Nayarisseri, Anuraj, Singh, Sanjeev Kumar
Format: Artigo
Jezik:Inglês
Izdano: Biomedical Informatics 2019
Teme:
Research Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6677907/
https://ncbi.nlm.nih.gov/pubmed/31435160
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.6026/97320630015139
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki